Targeted treatment of refractory primitive neuroectodermal tumor arising from an immature teratoma with crizotinib leading to a sustained response-Reference-Cited by-同舟云学术

Targeted treatment of refractory primitive neuroectodermal tumor arising from an immature teratoma with crizotinib leading to a sustained response

Published:2023-01 Issue:1 Volume:11 Page:
ISSN:2050-0904
Container-title:Clinical Case Reports
language:en
Short-container-title:Clinical Case Reports

Author:

Snyder Benjamin M.¹^ORCID,Lion Alex H.¹,Helvie Amy E.²,Marshall Mark S.¹,Ferguson Michael J.¹^ORCID

Affiliation:

1. Department of Pediatrics Indiana University School of Medicine Indianapolis Indiana USA

2. Department of Pharmacy Riley Hospital for Children at IU Health Indianapolis Indiana USA

Abstract

AbstractHere we present a case of metastatic PNET which arose from an immature teratoma that was refractory to standard Ewing sarcoma chemotherapy. This PNET was determined to have elevated levels of ALK protein via IHC. The patient was treated with crizotinib on a palliative basis with a sustained response.

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccr3.6779

Reference21 articles.

1. The evolution of the diagnosis and understanding of primitive and embryonic neoplasms in children: living through an epoch;Dehner LP;Mod Pathol,1998

2. Primitive Neuroectodermal Tumors of the Female Genital Tract

3. Ovarian primary primitive neuroectodermal tumor: a review of cases at PUMCH and in the published literature

4. Primitive neuroectodermal tumors in patients with testicular germ cell tumors usually resemble pediatric-type central nervous system embryonal neoplasms and lack chromosome 22 rearrangements

5. The Ewing Family of Tumors -- A Subgroup of Small-Round-Cell Tumors Defined by Specific Chimeric Transcripts